NCT07577973 The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension
| NCT ID | NCT07577973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | PRIMARY HYPERTENSION |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2026-09-07 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2026-09-07 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18-65 years 2. Diagnosed with primary hypertension (Stage 1 or 2) 3. Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg 4. Taking antihypertensive medication 5. Able to understand and communicate in Turkish 6. Willing to provide written informed consent Exclusion Criteria: 1. Secondary hypertension 2. Pregnancy or lactation 3. Severe cardiovascular disease (heart failure, myocardial infarction within 6 months) 4. Stroke history within 6 months 5. Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3) 6. Peripheral neuropathy affecting sensation 7. Current use of anticoagulant therapy 8. Participation in another clinical trial within 30 days
Contact & Investigator
Saadet Can Cicek, Associate Professor,PhD
PRINCIPAL INVESTIGATOR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT07577973 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying PRIMARY HYPERTENSION. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07577973 currently recruiting?
Yes, NCT07577973 is actively recruiting participants. Contact the research team at seymanurarslan@duzce.edu.tr for enrollment information.
Where is the NCT07577973 trial being conducted?
This trial is being conducted at Center, Turkey (Türkiye).
Who is sponsoring the NCT07577973 clinical trial?
NCT07577973 is sponsored by Abant Izzet Baysal University. The principal investigator is Saadet Can Cicek, Associate Professor,PhD at Abant Izzet Baysal University. The trial plans to enroll 72 participants.